African Surgical OutcomeS-2 (ASOS-2) Trial
ASOS-2
1 other identifier
interventional
27,507
1 country
1
Brief Summary
An international, multicentre, African cluster randomised trial. Primary objective : To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces overall in-hospital mortality in surgical patients aged 18 years and over in Africa. Primary outcome measure: In-hospital mortality, censored at 30 days if the patient is still alive and in-hospital. Secondary objective: To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces the overall incidence of the composite of severe in-hospital complications and mortality in adult surgical patients aged 18 years and over in Africa. Secondary outcome measure: Composite of severe in-hospital complications and mortality, censored at 30 days if the patient is still alive and in-hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable surgery
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2019
CompletedFirst Posted
Study publicly available on registry
February 26, 2019
CompletedStudy Start
First participant enrolled
May 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedSeptember 10, 2020
September 1, 2020
1.3 years
February 20, 2019
September 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
In hospital mortality.
Number of Participants with In hospital mortality
In-hospital, and censored at 30 days after surgery if still in-hospital.
Secondary Outcomes (1)
Composite of severe in-hospital complications and mortality
In-hospital, and censored at 30 days after surgery if still in-hospital.
Other Outcomes (7)
In-hospital severe superficial or deep surgical site, or body cavity infection
In-hospital, and censored at 30 days after surgery if still in-hospital.
In-hospital severe urinary tract or acute kidney injury
In-hospital, and censored at 30 days after surgery if still in-hospital.
In-hospital severe bloodstream infection or acute respiratory distress syndrome
In-hospital, and censored at 30 days after surgery if still in-hospital.
- +4 more other outcomes
Study Arms (2)
Intervention arm
OTHERPatients randomised to increased postoperative surveillance.
Control arm
OTHERPatients randomised to usual postoperative care.
Interventions
Increased postoperative surveillance can include either of the following; i) admission to a higher care ward than had been planned at the time of surgery, ii) an increase in the frequency of nursing observations in the postoperative period, iii) ensuring that the patient is placed in view of the nursing station, and not in a remote location in the postoperative ward, or iv) allowing family members to stay with the patient in the ward in the postoperative period.
Participating sites randomised to the control arm will provide usual postoperative care to patients. The care will be left to the discretion of the healthcare providers.
Eligibility Criteria
You may qualify if:
- All consecutive adult patients aged 18 years and over admitted to participating centres undergoing elective and non-elective surgery
You may not qualify if:
- Prior participation in ASOS-2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Cape Townlead
- Bill and Melinda Gates Foundationcollaborator
Study Sites (1)
Groote Schuur Hospital
Cape Town, Western Cape, 8001, South Africa
Related Publications (3)
Biccard BM, Madiba TE, Kluyts HL, Munlemvo DM, Madzimbamuto FD, Basenero A, Gordon CS, Youssouf C, Rakotoarison SR, Gobin V, Samateh AL, Sani CM, Omigbodun AO, Amanor-Boadu SD, Tumukunde JT, Esterhuizen TM, Manach YL, Forget P, Elkhogia AM, Mehyaoui RM, Zoumeno E, Ndayisaba G, Ndasi H, Ndonga AKN, Ngumi ZWW, Patel UP, Ashebir DZ, Antwi-Kusi AAK, Mbwele B, Sama HD, Elfiky M, Fawzy MA, Pearse RM; African Surgical Outcomes Study (ASOS) investigators. Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study. Lancet. 2018 Apr 21;391(10130):1589-1598. doi: 10.1016/S0140-6736(18)30001-1. Epub 2018 Jan 3.
PMID: 29306587BACKGROUNDVickery N, Stephens T, du Toit L, van Straaten D, Pearse R, Torborg A, Rolt L, Puchert M, Martin G, Biccard B; ASOS-2 Investigators. Understanding the performance of a pan-African intervention to reduce postoperative mortality: a mixed-methods process evaluation of the ASOS-2 trial. Br J Anaesth. 2021 Nov;127(5):778-788. doi: 10.1016/j.bja.2021.07.001. Epub 2021 Aug 24.
PMID: 34446223DERIVEDASOS-2 Investigators. Enhanced postoperative surveillance versus standard of care to reduce mortality among adult surgical patients in Africa (ASOS-2): a cluster-randomised controlled trial. Lancet Glob Health. 2021 Oct;9(10):e1391-e1401. doi: 10.1016/S2214-109X(21)00291-6. Epub 2021 Aug 19.
PMID: 34418380DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Bruce M Biccard, MD, PhD
University of Cape Town
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Anaesthetist
Study Record Dates
First Submitted
February 20, 2019
First Posted
February 26, 2019
Study Start
May 6, 2019
Primary Completion
August 31, 2020
Study Completion
August 31, 2020
Last Updated
September 10, 2020
Record last verified: 2020-09